PharmiWeb.com - Global Pharma News & Resources
PharmiWeb Today Story
NEXT PHASE OF LEADING HEALTH INNOVATION CAMPUS ANNOUNCED

Manchester’s leading health innovation campus, Citylabs, is set to expand again following high levels of demand as it continues to grow its presence as an international hub for genomics and precision medicine. 

Manchester Science Partnerships (MSP) and Manchester University NHS Foundation Trust (MFT) have unveiled plans to develop Citylabs 4.0, a new £35 million development which will grow the existing Citylabs campus by 125,000 sq ft.

The Joint Venture partnership between MSP and MFT, the UK's largest NHS provider Trust, is the first of its kind, with the first phase - Citylabs 1.0 - already home to a thriving cluster of diagnostics, medtech, digital health and genomics businesses who are driving the future of medicine and healthcare.

The new development represents another step forward for Manchester’s Oxford Road Corridor innovation district, Europe’s largest clinical academic campus and one of the North of England’s most important commercial areas, generating around £3bn in GVA each year.

Subject to planning approval by Manchester City Council, Citylabs 4.0 will be built at the south  of the MFT Oxford Road campus, adjacent to Citylabs 2.0 & 3.0, and provide 7 floors of office and lab space where brilliant research will be translated into new healthcare diagnostics and treatments which can then be quickly adopted into Manchester’s health system. 

Businesses at Citylabs have access to clinical and academic collaborators located on the  campus, and an extensive programme of business support including advice on funding sources, new markets, and profe…

Read More...
NEXT PHASE OF LEADING HEALTH INNOVATION CAMPUS ANNOUNCED

Articles